Join
Live feed
·
PRReleasevia Quantisnow
AMAG Pharmaceuticals, Inc. logo

AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for Clinically Indicated Pregnant Patients

ByQuantisnow·Wall Street's wire, on your screen.
AMAG· AMAG Pharmaceuticals, Inc.
Health Care
Full content unavailable. See the original source below.
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AMAG (AMAG Pharmaceuticals, Inc.) and more on Quantisnow.